series-b
Stage
2
Investors
About
NeoTract develops and manufactures minimally invasive medical devices aimed at treating benign prostatic hyperplasia, most notably through its UroLift system used by urologists.
Explore NEOTRACT's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.